Literature DB >> 19446653

Multifunctional magnetic nanoparticles for targeted delivery.

Arun Kumar1, Prasanna K Jena, Sumita Behera, Richard F Lockey, Subhra Mohapatra, Shyam Mohapatra.   

Abstract

A major problem associated with drug therapy is the inability to deliver pharmaceuticals to a specific site of the body without causing nonspecific toxicity. Development of magnetic nanoparticles and techniques for their safe transport and concentration in specific sites in the body would constitute a powerful tool for gene/drug therapy in vivo. Furthermore, drug delivery in vitro could improve further if the drugs were modified with antibodies, proteins, or ligands. For in vivo experiments, magnetic nanoparticles were conjugated with plasmid DNA expressing enhanced green fluorescent protein (EGFP) and then coated with chitosan. These particles were injected into mice through the tail vein and directed to the heart and kidneys by means of external magnets of 25 gauss or 2kA-kA/m. These particles were concentrated in the lungs, heart, and kidneys of mice, and the expression of EGFP in these sites were monitored. The expression of EGFP in specific locations was visualized by whole-body fluorescent imaging, and the concentration of these particles in the designated body locations was confirmed by transmission electron microscopy. In another model system, we used atrial natriuretic peptide and carcinoembryonic antigen antibodies coupled to the chitosan-coated magnetic nanoparticles to target cells in vitro. The present work demonstrates that a simple external magnetic field is all that is necessary to target a drug to a specific site inside the body without the need to functionalize the nanoparticles. However, the option to use magnetic targeting with external magnets on functionalized nanoparticles could prove as a more efficient means of drug delivery. FROM THE CLINICAL EDITOR: This paper addresses targeted drug delivery with magnetic nanoparticles. The authors demonstrate that a simple external magnetic field is sufficient to target a drug to specific sites in the body without the need for functionalized nanoparticles, at least in selected organs and diseases. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19446653      PMCID: PMC3319306          DOI: 10.1016/j.nano.2009.04.002

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  10 in total

1.  Magnetic resonance of a dextran-coated magnetic fluid intravenously administered in mice.

Authors:  L M Lacava; Z G Lacava; M F Da Silva; O Silva; S B Chaves; R B Azevedo; F Pelegrini; C Gansau; N Buske; D Sabolovic; P C Morais
Journal:  Biophys J       Date:  2001-05       Impact factor: 4.033

2.  Blood-specific whole-body electromagnetic hyperthermia.

Authors:  M Babincová; P Sourivong; D Leszczynska; P Babinec
Journal:  Med Hypotheses       Date:  2000-12       Impact factor: 1.538

Review 3.  Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications. A review.

Authors:  B Bonnemain
Journal:  J Drug Target       Date:  1998       Impact factor: 5.121

Review 4.  Biomedical applications of nanotechnology--implications for drug targeting and gene therapy.

Authors:  S S Davis
Journal:  Trends Biotechnol       Date:  1997-06       Impact factor: 19.536

5.  Biomimetic amplification of nanoparticle homing to tumors.

Authors:  Dmitri Simberg; Tasmia Duza; Ji Ho Park; Markus Essler; Jan Pilch; Lianglin Zhang; Austin M Derfus; Meng Yang; Robert M Hoffman; Sangeeta Bhatia; Michael J Sailor; Erkki Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-10       Impact factor: 11.205

6.  Magnetoswitchable electrochemistry gated by alkyl-chain-functionalized magnetic nanoparticles: control of diffusional and surface-confined electrochemical processes.

Authors:  Eugenii Katz; Ronan Baron; Itamar Willner
Journal:  J Am Chem Soc       Date:  2005-03-23       Impact factor: 15.419

7.  Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system.

Authors:  U Gaur; S K Sahoo; T K De; P C Ghosh; A Maitra; P K Ghosh
Journal:  Int J Pharm       Date:  2000-07-20       Impact factor: 5.875

Review 8.  Targeted drug delivery via the folate receptor.

Authors:  J Sudimack; R J Lee
Journal:  Adv Drug Deliv Rev       Date:  2000-03-30       Impact factor: 15.470

Review 9.  Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging.

Authors:  Y X Wang; S M Hussain; G P Krestin
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

Review 10.  Clinical applications of magnetic drug targeting.

Authors:  A S Lübbe; C Alexiou; C Bergemann
Journal:  J Surg Res       Date:  2001-02       Impact factor: 2.192

  10 in total
  32 in total

1.  Uptake and transport of superparamagnetic iron oxide nanoparticles through human brain capillary endothelial cells.

Authors:  L B Thomsen; T Linemann; K M Pondman; J Lichota; K S Kim; R J Pieters; G M Visser; T Moos
Journal:  ACS Chem Neurosci       Date:  2013-08-26       Impact factor: 4.418

2.  Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy.

Authors:  Mohamed O Abdalla; Prasanthi Karna; Hari Krishna Sajja; Hui Mao; Clayton Yates; Timothy Turner; Ritu Aneja
Journal:  J Control Release       Date:  2010-11-01       Impact factor: 9.776

Review 3.  Applications of nanoparticles in the detection and treatment of kidney diseases.

Authors:  Chris Brede; Vinod Labhasetwar
Journal:  Adv Chronic Kidney Dis       Date:  2013-11       Impact factor: 3.620

Review 4.  Myocardial gene transfer: routes and devices for regulation of transgene expression by modulation of cellular permeability.

Authors:  Michael G Katz; Anthony S Fargnoli; Charles R Bridges
Journal:  Hum Gene Ther       Date:  2013-04-01       Impact factor: 5.695

5.  Development of multifunctional nanoparticles towards applications in non-invasive magnetic resonance imaging and axonal tracing.

Authors:  Yan Du; Yubo Qin; Zizhen Li; Xiuying Yang; Jingchang Zhang; Harrison Westwick; Eve Tsai; Xudong Cao
Journal:  J Biol Inorg Chem       Date:  2017-10-25       Impact factor: 3.358

6.  Transferrin-conjugated, fluorescein-loaded magnetic nanoparticles for targeted delivery across the blood-brain barrier.

Authors:  Feng Yan; Ying Wang; Shenzhi He; Shuting Ku; Wei Gu; Ling Ye
Journal:  J Mater Sci Mater Med       Date:  2013-06-23       Impact factor: 3.896

7.  Targeting kidneys by superparamagnetic allopurinol loaded chitosan coated nanoparticles for the treatment of hyperuricemic nephrolithiasis.

Authors:  Gurpreet Kandav; D C Bhatt; Deepak Kumar Jindal
Journal:  Daru       Date:  2019-11-05       Impact factor: 3.117

8.  Superparamagnetic iron oxide nanotheranostics for targeted cancer cell imaging and pH-dependent intracellular drug release.

Authors:  Peng Zou; Yanke Yu; Y Andrew Wang; Yanqiang Zhong; Amanda Welton; Craig Galbán; Shaomeng Wang; Duxin Sun
Journal:  Mol Pharm       Date:  2010-09-29       Impact factor: 4.939

Review 9.  Targeted imaging and therapy of brain cancer using theranostic nanoparticles.

Authors:  Mahaveer Swaroop Bhojani; Marcian Van Dort; Alnawaz Rehemtulla; Brian D Ross
Journal:  Mol Pharm       Date:  2010-10-27       Impact factor: 4.939

Review 10.  The road ahead: working towards effective clinical translation of myocardial gene therapies.

Authors:  Michael G Katz; Anthony S Fargnoli; Richard D Williams; Charles R Bridges
Journal:  Ther Deliv       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.